Provided by Tiger Trade Technology Pte. Ltd.

Solid Biosciences

8.88
-0.1900-2.09%
Volume:553.68K
Turnover:4.95M
Market Cap:952.16M
PE:-4.75
High:9.36
Open:9.23
Low:8.75
Close:9.07
52wk High:11.45
52wk Low:3.79
Shares:107.23M
Float Shares:64.81M
Volume Ratio:0.86
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8709
EPS(LYR):-1.9922
ROE:-65.50%
ROA:-36.38%
PB:2.55
PE(LYR):-4.46

Loading ...

Press Release: Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
May 13

Solid Biosciences Q1 FY26 net loss widens 44.4% to $56.74 million

Reuters
·
May 13

Solid Biosciences Inc expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
May 11

Solid Biosciences doses part participant in IMPACT DUCHENNE study

TIPRANKS
·
May 08

Solid Biosciences doses first patient in Phase 3 SGT-003 Duchenne trial

Reuters
·
May 07

Solid Biosciences Doses First Participant in Phase 3 Impact Duchenne Clinical Trial Evaluating Sgt-003 in Duchenne Muscular Dystrophy

THOMSON REUTERS
·
May 07

Solid Biosciences grants 8,070 inducement RSUs to new hire under Nasdaq rule

Reuters
·
May 02

Solid Biosciences to present 16 abstracts at ASGCT annual meeting

Reuters
·
Apr 30

Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy

GlobeNewswire
·
Apr 30

Solid Biosciences receives orphan drug designation for SGT-003 from EC

TIPRANKS
·
Apr 28

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire
·
Apr 28

Barinthus Biotherapeutics appoints Douglas Swirsky as CFO effective May 1

Reuters
·
Apr 23

Solid Biosciences Adjusts Board Classes in Governance Move

TIPRANKS
·
Apr 11

Solid Biosciences announces annual shareholder meeting agenda includes proposal to double authorized shares

Reuters
·
Apr 11

Solid Biosciences shifts Ilan Ganot to Class I director role in board reshuffle

Reuters
·
Apr 11

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire
·
Apr 07

Solid Biosciences Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 25

J.P. Morgan Issues a Buy Rating on Solid Biosciences (SLDB)

TIPRANKS
·
Mar 25

Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE) and Solid Biosciences (SLDB)

TIPRANKS
·
Mar 23

Solid Biosciences Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 23